Intracerebral injections of diluted Aβ‐containing brain extracts from AD patients or APP transgenic mice have been shown to induce brain Aβ synthesis and related pathological changes in a time‐ and dose‐dependent manner.32 This evidence concerns the gene APP and Alzheimer disease.